Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CALL
Linde
LIN
$221B
| $5.33M | ﹤0.01% |
15,000
-3,000
| -17% | -$1M |
|
1477
Meritage Homes
MTH
$4.58B
| $5.33M | ﹤0.01% |
91,334
-83,402
| -48% | -$4.49M |
|
1478
Chewy
CHWY
$9.25B
| $5.33M | ﹤0.01% |
142,618
-89,033
| -38% | -$3.69M |
|
1479
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
| $5.33M | ﹤0.01% |
118,693
-477,270
| -80% | -$20.5M |
|
|
JBGS
1480
JBG SMITH
JBGS
$818M
| $5.33M | ﹤0.01% |
353,764
-300,300
| -46% | -$5.33M |
|
1481
Bloomin' Brands
BLMN
$741M
| $5.32M | ﹤0.01% |
207,420
-44,012
| -18% | -$1.09M |
|
1482
PUT
iShares Silver Trust
SLV
$28B
| $5.31M | ﹤0.01% |
240,000
-1,173,000
| -83% | -$24.3M |
|
1483
TXO Partners LP
TXO
$742M
| $5.3M | ﹤0.01% |
+229,458
| New | +$5.28M |
|
1484
Universal Display
OLED
$3.68B
| $5.3M | ﹤0.01% |
34,151
+848
| +3% | +$114K |
|
1485
PUT
Goodyear
GT
$2B
| $5.29M | ﹤0.01% |
480,000
| – | – |
|
|
ALEX
1486
DELISTED
Alexander & Baldwin
ALEX
| $5.28M | ﹤0.01% |
279,409
+2,884
| +1% | +$54.7K |
|
1487
Spectrum Brands
SPB
$2.04B
| $5.28M | ﹤0.01% |
79,763
+76,370
| +2,251% | +$4.82M |
|
1488
SPS Commerce
SPSC
$2.64B
| $5.28M | ﹤0.01% |
34,647
+16,316
| +89% | +$2.32M |
|
1489
Cabot Corp
CBT
$4.54B
| $5.28M | ﹤0.01% |
68,829
+18,378
| +36% | +$1.38M |
|
|
MRTX
1490
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.27M | ﹤0.01% |
141,860
-86,565
| -38% | -$3.89M |
|
1491
Cullen/Frost Bankers
CFR
$10.3B
| $5.27M | ﹤0.01% |
50,018
+16,976
| +51% | +$2.11M |
|
|
VMCA
1492
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
| $5.26M | ﹤0.01% |
500,000
| – | – |
|
1493
Roadzen
RDZN
$97.2M
| $5.22M | ﹤0.01% |
500,000
| – | – |
|
1494
CALL
PG&E
PCG
$38.3B
| $5.22M | ﹤0.01% |
+322,600
| New | +$5.1M |
|
|
CMA
1495
DELISTED
Comerica
CMA
| $5.22M | ﹤0.01% |
120,135
-54,537
| -31% | -$3.5M |
|
|
ENTF
1496
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Class A Ordinary Shares
ENTF
| $5.21M | ﹤0.01% |
500,000
| – | – |
|
|
VTNR
1497
DELISTED
Vertex Energy, Inc
VTNR
| $5.21M | ﹤0.01% |
527,383
+12,861
| +2% | +$102K |
|
1498
Columbia Banking Systems
COLB
$8.84B
| $5.21M | ﹤0.01% |
243,193
+165,107
| +211% | +$4.59M |
|
|
PPYA
1499
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
| $5.2M | ﹤0.01% |
500,000
| – | – |
|
|
KRTX
1500
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.2M | ﹤0.01% |
28,609
-836
| -3% | -$160K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.